• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Phaarmasia Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2597.0
  • ISIN : INE486I01016
29.31 -1 (-1.97%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    29.31

  • Today’s High

    29.31

  • Open

    29.31

  • Perv Close

    29.90

  • 52W Low

    23.60

  • 52W High

    64.75

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    20.02

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.34

  • Debt-Equity Ratio

    -1.97

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    20.02

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.83

  • BV (₹)

    8.30

  • Sales( ₹ in Cr.)

    30.59

  • NP (in Cr.)

    -0.52

  • NP Var(%)

    59.0

  • Div%

    0.0

  • CPS (₹)

    -0.30

  • EPS (₹)

    -0.80

  • Traded Value (₹ in Lakhs)

    20.02

  • 52 Week High

    64.75

  • 52 Week Low

    23.60

  • Price BSE

    29.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    20.02

  • P/C Ratio

    -113.60

  • P/E Ratio

    -38.20

  • Price Vs.BV

    -0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 30.59 27.49 17.22 19.90 24.45 25.65
Excise Duty 30.59 27.49 17.22 19.89 23.45 24.26
Net Sales 30.59 27.49 17.22 19.90 24.45 25.65
Other Income 0.66 0.52 0.47 0.89 0.58 0.60
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 31.25 28.01 17.69 20.79 25.03 24.80
EXPENDITURE :
Raw Materials 30.59 27.49 17.22 19.89 23.45 24.26
Power & Fuel Cost 30.59 27.49 17.22 19.89 23.45 24.26
Employee Cost 1.76 1.64 1.38 1.50 1.58 1.73
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling & Administrative Expenses 1.43 1.49 1.17 1.04 1.35 2.54
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Less : Pre-operative Expenses Capitalised :
Total Expenditure 31.80 29.44 19.25 20.31 24.07 23.97
Operating Profit 3.63 3.45 2.54 2.84 2.91 3.00
Interest 0.04 0.04 0.00 0.01 0.04 0.04
Gross Profit -0.55 -1.43 -1.56 0.48 0.96 0.83
Depreciation 0.34 0.36 0.29 0.34 0.40 0.46
Profit Before Tax -0.55 -1.43 -1.56 0.48 0.96 0.83
Tax 0.00 0.00 0.00 0.18 0.27 0.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 -0.17 -0.02 -0.02 0.16 -0.20
Reported Net Profit -0.52 -1.26 -1.55 0.31 0.54 0.78
Extraordinary Items -0.55 -1.43 -1.56 0.48 0.96 0.83
Adjusted Net Profit -0.52 -1.26 -1.55 0.31 0.54 0.78
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.52 -1.26 -1.55 0.31 0.54 0.78
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.76 -1.84 -2.27 0.46 0.79 1.14
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    73.51%

  • Public Share Holding

    26.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,018,732 73.51 5,018,732 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,018,732 73.51 5,018,732 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 240 0.00 0 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,720 0.05 0 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,960 0.06 0 7
2] Non Institution
Bodies Corporate 10,158 0.15 5,707 61
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,879 0.10 6,879 10
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 370,611 5.43 241,888 6
Individuals holding nominal share capital up to Rs. 1 lakh 1,416,620 20.75 468,018 20,526
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,804,268 26.43 722,492 20,603
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,826,960 100.00 5,741,224 20,612

Company Background

Phaarmasia LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Phaarmasia Ltd
  • BSE Code : 2597.0
  • ISIN : INE486I01016

  • Incorporation Year

    1981

  • Registered Office

    16 Phase III
    I D A Jeedimetla, Hyderabad,
    Telangana-500055

  • Telephone

    91-40-23095002/23095690

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Urvashi Bhatia

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Phaarmasia Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Phaarmasia 29.31 31.25 30.59 -33.69 0.00
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92